NADPH oxidases: Novel therapeutic targets for neurodegenerative diseases

Trends in Pharmacological Sciences

Volumn 33, Issue 6, 2012, Pages 295-303

  Gao, Hui Ming ^a   Zhou, Hui ^a   Hong, Jau Shyong ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN; APOCYNIN; CD11B ANTIGEN; DEXTROMETHORPHAN; DIPHENYLIODONIUM SALT; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; GALANTAMINE; HYDROGEN SULFIDE; IBUPROFEN; MINOCYCLINE; PATTERN RECOGNITION RECEPTOR; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4;

ALLERGIC ENCEPHALOMYELITIS; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; CENTRAL NERVOUS SYSTEM; DEGENERATIVE DISEASE; DISEASE MODEL; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG SPECIFICITY; DRUG TARGETING; ENZYME ACTIVATION; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LOCALIZATION; ENZYME REPRESSION; HUMAN; IN VITRO STUDY; LOW DRUG DOSE; MACROGLIA; MICROGLIA; MULTIPLE SCLEROSIS; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NONHUMAN; OXIDATIVE COUPLING; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; STROKE;

ALZHEIMER DISEASE; ANIMALS; ANTIOXIDANTS; ASTROCYTES; DRUG DISCOVERY; ENZYME INHIBITORS; HUMANS; MEMBRANE GLYCOPROTEINS; MICE; NADPH OXIDASE; NEURONS; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; PARKINSON DISEASE; PHAGOCYTES; REACTIVE OXYGEN SPECIES; SUPEROXIDES;

EID: 84861854211     PISSN: 01656147     EISSN: 18733735     Source Type: Journal    
DOI: 10.1016/j.tips.2012.03.008     Document Type: Review

References (107)

1. Barnham, K.J. et al. (2004) Neurodegenerative diseases and oxidative stress. Nat. Rev. Drug Discov. 3, 205-214
2. Zhou, C. et al. (2008) Oxidative stress in Parkinson's disease: a mechanism of pathogenic and therapeutic significance. Ann. N. Y. Acad. Sci. 1147, 93-104
3. Drummond, G.R. et al. (2011) Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets. Nat. Rev. Drug Discov. 10, 453-471
4. Fatehi-Hassanabad, Z. et al. (2010) Reactive oxygen species and endothelial function in diabetes. Eur. J. Pharmacol. 636, 8-17
5. Bedard, K. and Krause, K.H. (2007) The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol. Rev. 87, 245-313 (Pubitemid 46209993)
6. Sorce, S. and Krause, K.H. (2009) NOX enzymes in the central nervous system: from signaling to disease. Antioxid. Redox Signal. 11, 2481-2504
7. Yu, L. et al. (1998) Gp91(phox) is the heme binding subunit of the superoxide-generating NADPH oxidase. Proc. Natl. Acad. Sci. U.S.A. 95, 7993-7998
8. Freeman, J.L. and Lambeth, J.D. (1996) NADPH oxidase activity is independent of p47phox in vitro. J. Biol. Chem. 271, 22578-22582 (Pubitemid 26304697)
9. Mizrahi, A. et al. (2006) Assembly of the phagocyte NADPH oxidase complex: chimeric constructs derived from the cytosolic components as tools for exploring structure-function relationships. J. Leukoc. Biol. 79, 881-895 (Pubitemid 44835573)
10. Zhou, H. et al. (2012) Rotenone activates phagocyte NADPH oxidase by binding to its membrane subunit gp91phox. Free Radic. Biol. Med. 52, 303-313
11. Cheng, G. and Lambeth, J.D. (2004) NOXO1, regulation of lipid binding, localization, and activation of Nox1 by the Phox homology (PX) domain. J. Biol. Chem. 279, 4737-4742 (Pubitemid 38199068)
12. Valente, A.J. et al. (2007) NOX1 NADPH oxidase regulation by the NOXA1 SH3 domain. Free Radic. Biol. Med. 43, 384-396 (Pubitemid 46977629)
13. Cheng, G. et al. (2004) Nox3 regulation by NOXO1, p47phox, and p67phox. J. Biol. Chem. 279, 34250-34255 (Pubitemid 39318048)
14. Ueno, N. et al. (2005) The NADPH oxidase Nox3 constitutively produces superoxide in a p22phox-dependent manner: its regulation by oxidase organizers and activators. J. Biol. Chem. 280, 23328-23339 (Pubitemid 40853246)
15. Nisimoto, Y. et al. (2010) Constitutive NADPH-dependent electron transferase activity of the Nox4 dehydrogenase domain. Biochemistry 49, 2433-2442
16. von Loehneysen, K. et al. (2012) Constitutive NADPH oxidase 4 activity resides in the composition of the B-loop and the penultimate C-terminus. J. Biol. Chem. 287, 8737-8745
17. Babior, B.M. (2004) NADPH oxidase. Curr. Opin. Immunol. 16, 42-47
18. Gao, H.M. et al. (2011) Neuroinflammation and alpha-Synuclein dysfunction potentiate each other, driving chronic progression of neurodegeneration in a mouse model of Parkinson's disease. Environ. Health Perspect. 119, 807-814
19. Nakano, Y. et al. (2008) Mutation of the Cyba gene encoding p22phox causes vestibular and immune defects in mice. J. Clin. Invest. 118, 1176-1185 (Pubitemid 351364624)
20. Pao, M. et al. (2004) Cognitive function in patients with chronic granulomatous disease: a preliminary report. Psychosomatics 45, 230-234 (Pubitemid 38621532)
21. Kishida, K.T. et al. (2006) Synaptic plasticity deficits and mild memory impairments in mouse models of chronic granulomatous disease. Mol. Cell. Biol. 26, 5908-5920 (Pubitemid 44134344)
22. Brennan, A.M. et al. (2009) NADPH oxidase is the primary source of superoxide induced by NMDA receptor activation. Nat. Neurosci. 12, 857-863
23. Girouard, H. et al. (2009) NMDA receptor activation increases free radical production through nitric oxide and NOX2. J. Neurosci. 29, 2545-2552
24. Behrens, M.M. et al. (2007) Ketamine-induced loss of phenotype of fast-spiking interneurons is mediated by NADPH-oxidase. Science 318, 1645-1647 (Pubitemid 350233667)
25. Behrens, M.M. et al. (2008) Interleukin-6 mediates the increase in NADPH-oxidase in the ketamine model of schizophrenia. J. Neurosci. 28, 13957-13966
26. Zimmerman, M.C. et al. (2004) Requirement for Rac1-dependent NADPH oxidase in the cardiovascular and dipsogenic actions of angiotensin II in the brain. Circ. Res. 95, 532-539 (Pubitemid 39180933)
27. Wang, G. et al. (2004) NADPH oxidase contributes to angiotensin II signaling in the nucleus tractus solitarius. J. Neurosci. 24, 5516-5524 (Pubitemid 38812634)
28. Ibi, M. et al. (2006) NOX1/NADPH oxidase negatively regulates nerve growth factor-induced neurite outgrowth. Free Radic. Biol. Med. 40, 1785-1795
29. Munnamalai, V. and Suter, D.M. (2009) Reactive oxygen species regulate F-actin dynamics in neuronal growth cones and neurite outgrowth. J. Neurochem. 108, 644-661
30. Mander, P.K. et al. (2006) Microglia proliferation is regulated by hydrogen peroxide from NADPH oxidase. J. Immunol. 176, 1046-1052 (Pubitemid 43099705)
31. Marin-Teva, J.L. et al. (2004) Microglia promote the death of developing Purkinje cells. Neuron 41, 535-547 (Pubitemid 38253066)
32. Harrigan, T.J. et al. (2008) Activation of microglia with zymosan promotes excitatory amino acid release via volume-regulated anion channels: the role of NADPH oxidases. J. Neurochem. 106, 2449-2462
33. Barger, S.W. et al. (2007) Glutamate release from activated microglia requires the oxidative burst and lipid peroxidation. J. Neurochem. 101, 1205-1213
34. Abramov, A.Y. et al. (2005) Expression and modulation of an NADPH oxidase in mammalian astrocytes. J. Neurosci. 25, 9176-9184 (Pubitemid 41500826)
35. Ansari, M.A. and Scheff, S.W. (2011) NADPH-oxidase activation and cognition in Alzheimer disease progression. Free Radic. Biol. Med. 51, 171-178
36. Shimohama, S. et al. (2000) Activation of NADPH oxidase in Alzheimer's disease brains. Biochem. Biophys. Res. Commun. 273, 5-9 (Pubitemid 30426853)
37. de la Monte, S.M and Wands, J.R. (2006) Molecular indices of oxidative stress and mitochondrial dysfunction occur early and often progress with severity of Alzheimer's disease. J. Alzheimers Dis. 9, 167-181
38. Cheret, C. et al. (2008) Neurotoxic activation of microglia is promoted by a nox1-dependent NADPH oxidase. J. Neurosci. 28, 12039-12051
39. +)-induced oxidative stress and apoptosis in mesencephalic dopaminergic neuronal cells. Neurotoxicology 28, 988-997
40. Cristovao, A.C. et al. (2009) The role of NADPH oxidase 1-derived reactive oxygen species in paraquat-mediated dopaminergic cell death. Antioxid. Redox Signal. 11, 2105-2118
41. Marden, J.J. et al. (2007) Redox modifier genes in amyotrophic lateral sclerosis in mice. J. Clin. Invest. 117, 2913-2919 (Pubitemid 47529621)
42. Coyoy, A. et al. (2008) Role of NADPH oxidase in the apoptotic death of cultured cerebellar granule neurons. Free Radic. Biol. Med. 45, 1056-1064
43. Guemez-Gamboa, A. and Moran, J. (2009) NOX2 mediates apoptotic death induced by staurosporine but not by potassium deprivation in cerebellar granule neurons. J. Neurosci. Res. 87, 2531-2540
44. Ha, J.S. et al. (2010) Extracellular hydrogen peroxide contributes to oxidative glutamate toxicity. Brain Res. 1359, 291-297
45. Kleinschnitz, C. et al. (2010) Post-stroke inhibition of induced NADPH oxidase type 4 prevents oxidative stress and neurodegeneration. PLoS Biol. 8
46. Gao, H.M. and Hong, J.S. (2008) Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression. Trends Immunol. 29, 357-365
47. Philips, T. and Robberecht, W. (2011) Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease. Lancet Neurol. 10, 253-263
48. Glass, C.K. et al. (2010) Mechanisms underlying inflammation in neurodegeneration. Cell 140, 918-934
49. Gao, H.M. and Hong, J.S. (2011) Gene-environment interactions: key to unraveling the mystery of Parkinson's disease. Prog. Neurobiol. 94, 1-19
50. Milton, R.H. et al. (2008) CLIC1 function is required for beta-amyloid-induced generation of reactive oxygen species by microglia. J. Neurosci. 28, 11488-11499
51. Wilkinson, B. et al. (2006) Fibrillar beta-amyloid-stimulated intracellular signaling cascades require Vav for induction of respiratory burst and phagocytosis in monocytes and microglia. J. Biol. Chem. 281, 20842-20850 (Pubitemid 44115425)
52. Kim, S.Y. et al. (2007) ATP released from beta-amyloid-stimulated microglia induces reactive oxygen species production in an autocrine fashion. Exp. Mol. Med. 39, 820-827
53. Parvathenani, L.K. et al. (2003) P2X7 mediates superoxide production in primary microglia and is up-regulated in a transgenic mouse model of Alzheimer's disease. J. Biol. Chem. 278, 13309-13317 (Pubitemid 36800102)
54. Qin, L. et al. (2002) Microglia enhance beta-amyloid peptide-induced toxicity in cortical and mesencephalic neurons by producing reactive oxygen species. J. Neurochem. 83, 973-983 (Pubitemid 35316048)
55. Qin, B. et al. (2006) A key role for the microglial NADPH oxidase in APP-dependent killing of neurons. Neurobiol. Aging 27, 1577-1587 (Pubitemid 44349157)
56. Choi, S.H. et al. (2012) Inhibition of NADPH oxidase promotes alternative and anti-inflammatory microglial activation during neuroinflammation. J. Neurochem. 120, 292-301
57. Abramov, A.Y. et al. (2004) Beta-amyloid peptides induce mitochondrial dysfunction and oxidative stress in astrocytes and death of neurons through activation of NADPH oxidase. J. Neurosci. 24, 565-575 (Pubitemid 38112390)
58. Park, L. et al. (2008) Nox2-derived radicals contribute to neurovascular and behavioral dysfunction in mice overexpressing the amyloid precursor protein. Proc. Natl. Acad. Sci. U.S.A. 105, 1347-1352 (Pubitemid 351397056)
59. Wu, D.C. et al. (2003) NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease. Proc. Natl. Acad. Sci. U.S.A. 100, 6145-6150
60. Wu, D.C. et al. (2006) The inflammatory NADPH oxidase enzyme modulates motor neuron degeneration in amyotrophic lateral sclerosis mice. Proc. Natl. Acad. Sci. U.S.A. 103, 12132-12137
61. Zhang, W. et al. (2005) Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease. FASEB J. 19, 533-542 (Pubitemid 40471244)
62. Gao, H.M. et al. (2003) Synergistic dopaminergic neurotoxicity of the pesticide rotenone and inflammogen lipopolysaccharide: relevance to the etiology of Parkinson's disease. J. Neurosci. 23, 1228-1236
63. Gao, H.M. et al. (2002) Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson's disease. J. Neurochem. 81, 1285-1297
64. Gao, H.M. et al. (2003) Critical role for microglial NADPH oxidase in rotenone-induced degeneration of dopaminergic neurons. J. Neurosci. 23, 6181-6187
65. Gao, H.M. et al. (2003) Critical role of microglial NADPH oxidase-derived free radicals in the in vitro MPTP model of Parkinson's disease. FASEB J. 17, 1954-1956
66. Qin, L. et al. (2004) NADPH oxidase mediates lipopolysaccharide-induced neurotoxicity and proinflammatory gene expression in activated microglia. J. Biol. Chem. 279, 1415-1421 (Pubitemid 38082669)
67. Rodriguez-Pallares, J. et al. (2007) Mechanism of 6-hydroxydopamine neurotoxicity: the role of NADPH oxidase and microglial activation in 6-hydroxydopamine-induced degeneration of dopaminergic neurons. J. Neurochem. 103, 145-156 (Pubitemid 47404195)
68. Rodriguez-Pallares, J. et al. (2008) Brain angiotensin enhances dopaminergic cell death via microglial activation and NADPH-derived ROS. Neurobiol. Dis. 31, 58-73
69. Wu, X.F. et al. (2005) The role of microglia in paraquat-induced dopaminergic neurotoxicity. Antioxid. Redox Signal. 7, 654-661
70. Block, M.L. et al. (2004) Nanometer size diesel exhaust particles are selectively toxic to dopaminergic neurons: the role of microglia, phagocytosis, and NADPH oxidase. FASEB J. 18, 1618-1620 (Pubitemid 39561652)
71. Gao, X. et al. (2008) Formyl-methionyl-leucyl-phenylalanine-induced dopaminergic neurotoxicity via microglial activation: a mediator between peripheral infection and neurodegeneration? Environ. Health Perspect. 116, 593-598 (Pubitemid 351864273)
72. Kim, Y.S. et al. (2007) A pivotal role of matrix metalloproteinase-3 activity in dopaminergic neuronal degeneration via microglial activation. FASEB J. 21, 179-187
73. Gao, H. et al. (2011) HMGB1 acts on microglia Mac1 to mediate chronic neuroinflammation that drives progressive neurodegeneration. J. Neurosci. 31, 1081-1092
74. Wu, D.C. et al. (2002) Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease. J. Neurosci. 22, 1763-1771 (Pubitemid 35386294)
75. Zhang, W. et al. (2004) Neuroprotective effect of dextromethorphan in the MPTP Parkinson's disease model: role of NADPH oxidase. FASEB J. 18, 589-591
76. Liu, Y. et al. (2009) Expression of amyotrophic lateral sclerosis-linked SOD1 mutant increases the neurotoxic potential of microglia via TLR2. J. Biol. Chem. 284, 3691-3699
77. Marchetto, M.C. et al. (2008) Non-cell-autonomous effect of human SOD1 G37R astrocytes on motor neurons derived from human embryonic stem cells. Cell Stem Cell 3, 649-657
78. Harraz, M.M. et al. (2008) SOD1 mutations disrupt redox-sensitive Rac regulation of NADPH oxidase in a familial ALS model. J. Clin. Invest. 118, 659-670 (Pubitemid 351206555)
79. Li, Q. et al. (2011) ALSIN and SOD1G93A regulate endosomal ROS production by glial cells and pro-inflammatory pathways responsible for neurotoxicity. J. Biol. Chem. 286, 40151-40162
80. Li, J. et al. (2005) Peroxynitrite generated by inducible nitric oxide synthase and NADPH oxidase mediates microglial toxicity to oligodendrocytes. Proc. Natl. Acad. Sci. U.S.A. 102, 9936-9941
81. Liu, Y. et al. (2006) Suppression of microglial inflammatory activity by myelin phagocytosis: role of p47-PHOX-mediated generation of reactive oxygen species. J. Neurosci. 26, 12904-12913
82. Hultqvist, M. et al. (2004) Enhanced autoimmunity, arthritis, and encephalomyelitis in mice with a reduced oxidative burst due to a mutation in the Ncf1 gene. Proc. Natl. Acad. Sci. U.S.A. 101, 12646-12651 (Pubitemid 39122077)
83. van der Veen, R.C. et al. (2000) Superoxide prevents nitric oxide-mediated suppression of helper T lymphocytes: decreased autoimmune encephalomyelitis in nicotinamide adenine dinucleotide phosphate oxidase knockout mice. J. Immunol. 164, 5177-5183
84. Becanovic, K. et al. (2006) Advanced intercross line mapping of Eae5 reveals Ncf-1 and CLDN4 as candidate genes for experimental autoimmune encephalomyelitis. J. Immunol. 176, 6055-6064
85. Li, S. et al. (2011) Distinct role of nitric oxide and peroxynitrite in mediating oligodendrocyte toxicity in culture and in experimental autoimmune encephalomyelitis. Neuroscience 184, 107-119
86. Lehnardt, S. (2010) Innate immunity and neuroinflammation in the CNS: the role of microglia in Toll-like receptor-mediated neuronal injury. Glia 58, 253-263
87. Block, M.L. et al. (2007) Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat. Rev. Neurosci. 8, 57-69 (Pubitemid 46011999)
88. Zhang, D. et al. (2011) Microglial MAC1 receptor and PI3K are essential in mediating beta-amyloid peptide-induced microglial activation and subsequent neurotoxicity. J. Neuroinflamm. 8, 3
89. Hu, X. et al. (2008) Macrophage antigen complex-1 mediates reactive microgliosis and progressive dopaminergic neurodegeneration in the MPTP model of Parkinson's disease. J. Immunol. 181, 7194-7204
90. Liang, X. et al. (2008) The prostaglandin E2 EP2 receptor accelerates disease progression and inflammation in a model of amyotrophic lateral sclerosis. Ann. Neurol. 64, 304-314
91. Qian, L. et al. (2008) Potent anti-inflammatory and neuroprotective effects of TGF-beta1 are mediated through the inhibition of ERK and p47phox-Ser345 phosphorylation and translocation in microglia. J. Immunol. 181, 660-668
92. Qian, L. et al. (2007) Sinomenine, a natural dextrorotatory morphinan analog, is anti-inflammatory and neuroprotective through inhibition of microglial NADPH oxidase. J. Neuroinflamm. 4, 23
93. Yang, S. et al. (2006) Pituitary adenylate cyclase-activating polypeptide (PACAP) 38 and PACAP4-6 are neuroprotective through inhibition of NADPH oxidase: potent regulators of microglia-mediated oxidative stress. J. Pharmacol. Exp. Ther. 319, 595-603
94. Zhang, D. et al. (2008) Squamosamide derivative FLZ protects dopaminergic neurons against inflammation-mediated neurodegeneration through the inhibition of NADPH oxidase activity. J. Neuroinflamm. 5, 21
95. Zhang, F. et al. (2010) Resveratrol protects dopamine neurons against lipopolysaccharide-induced neurotoxicity through its antiinflammatory actions. Mol. Pharmacol. 78, 466-477
96. Liu, Y. et al. (2011) Verapamil protects dopaminergic neuron damage through a novel anti-inflammatory mechanism by inhibition of microglial activation. Neuropharmacology 60, 373-380
97. Choi, S.H. et al. (2005) Inhibition of thrombin-induced microglial activation and NADPH oxidase by minocycline protects dopaminergic neurons in the substantia nigra in vivo. J. Neurochem. 95, 1755-1765 (Pubitemid 41804071)
98. Zhang, F. et al. (2010) Inhibition of IkappaB kinase-beta protects dopamine neurons against lipopolysaccharide-induced neurotoxicity. J. Pharmacol. Exp. Ther. 333, 822-833
99. Hu, L.F. et al. (2010) Neuroprotective effects of hydrogen sulfide on Parkinson's disease rat models. Aging Cell 9, 135-146
100. Zhang, Q.G. et al. (2009) Estrogen attenuates ischemic oxidative damage via an estrogen receptor alpha-mediated inhibition of NADPH oxidase activation. J. Neurosci. 29, 13823-13836
101. Egea, J. et al. (2012) Galantamine elicits neuroprotection by inhibiting iNOS, NADPH oxidase and ROS in hippocampal slices stressed with anoxia/reoxygenation. Neuropharmacology 62, 1082-1090
102. Wilkinson, B.L. et al. (2012) Ibuprofen attenuates oxidative damage through NOX2 inhibition in Alzheimer's disease. Neurobiol. Aging 33, 197.e121-197.e132
103. Chechneva, O.V. et al. (2011) Low dose dextromethorphan attenuates moderate experimental autoimmune encephalomyelitis by inhibiting NOX2 and reducing peripheral immune cells infiltration in the spinal cord. Neurobiol. Dis. 44, 63-72
104. Kuhns, D.B. et al. (2010) Residual NADPH oxidase and survival in chronic granulomatous disease. N. Engl. J. Med. 363, 2600-2610
105. Heumuller, S. et al. (2008) Apocynin is not an inhibitor of vascular NADPH oxidases but an antioxidant. Hypertension 51, 211-217 (Pubitemid 351159930)
106. Vejrazka, M. et al. (2005) Apocynin inhibits NADPH oxidase in phagocytes but stimulates ROS production in non-phagocytic cells. Biochim. Biophys. Acta 1722, 143-147 (Pubitemid 40299004)
107. Jaquet, V. et al. (2009) Small-molecule NOX inhibitors: ROS-generating NADPH oxidases as therapeutic targets. Antioxid. Redox Signal. 11, 2535-2552